Pluripotent stem cells (PSCs) have the ability to generate all 220+ cell types found within the human body. This unique attribute means they offer great potential for basic research, drug discovery and cell replacement therapies.

In 2011 Lonza began the development of a clinical grade master cell bank to support researchers in the field. This process uncovered the need for a wider range of tools to support those working with PSCs in order to help solve a number of technical challenges.

Today Lonza is providing these tools, as well as a range of educational materials to support the users of PSCs. As part of this process, the 60-minute webinar is aimed at helping researchers streamline PSC workflow through various stages of research and development enabling them to save time, effort and money. The topics covered will include: 

• Technical challenges of induced pluripotent stem cell (iPSC)-based therapies
• General considerations for iPSC researchers with clinical aspirations
• The new L7™ hiPSC Reprogramming Bundle for the generation of peripheral blood mononuclear cells (PBMC)-derived iPSCs
• The L7™ hPSC Culture System for xeno-free, defined culturing of human pluripotent stem cells (hPSCs)
• Application examples
• A live Q&A session

Interested parties can register to attend the free webinar by selecting their preferred date below and clicking on the link:

·        Tuesday, 16 June 2015 – 11 AM PDT (Los Angeles) / 2 PM EDT (New York)

Speaker: Andrew Winner, Scientific Support Specialist, Lonza Bioscience Solutions 

·       Wednesday, 17 June 2015 – 9 AM BST (London) / 10 AM CST (Berlin / 5 PM JST (Tokyo)

Speaker: Dr. Heiko Bueth, Scientific Support Specialist, Lonza Bioscience Solutions 

Those interested in the topic but unable to join the webinar are invited to visit Lonza’s online archiveto access the content at a later date.